Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Fulgent Genetics, Inc. (FLGT) vs Exagen Inc. (XGN)

Fulgent Genetics, Inc. and Exagen Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $593.0M against $233.3M — 2.5× the size. Exagen Inc. grew revenue faster over the last twelve months: 20.8% against 6.83%. Fulgent Genetics, Inc. has the higher net margin (−26.1% vs −26.6%) and the higher return on invested capital (−10.3% vs −68.3%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 9 and Exagen Inc. on 9.

Valuation

Metric FLGT XGN Diagnostics & Research median
P/E n/m n/m 33.95
P/S 1.92 2.96 4.87
P/B 0.62 17.25 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 1.18 2.96 5.66
Earnings yield (12.70%) (9.29%) (1.75%)
Free cash flow yield (16.69%) (3.60%) (0.13%)

Profitability

Metric FLGT XGN Diagnostics & Research median
Gross margin 35.58% 58.64% 50.89%
Operating margin (37.75%) (18.58%) (8.57%)
Net margin (26.05%) (26.61%) (6.37%)
Free cash flow margin (32.04%) (10.66%) 0.00%
Return on equity (8.01%) (113.82%) (2.92%)
Return on assets (7.37%) (34.19%) (6.71%)
Return on invested capital (10.34%) (68.33%) 0.00%

Growth

Metric FLGT XGN Diagnostics & Research median
Revenue growth (TTM) 6.83% 20.83% 7.69%
EPS growth (last fiscal year) (39.72%) (12.05%) —
Revenue growth, 5-year CAGR (5.21%) 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLGT XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.11
Current ratio 6.34 3.18 2.02
Net debt to EBITDA 4.66 0.68 0.78

Dividend

Metric FLGT XGN Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric FLGT XGN Diagnostics & Research median
Market cap 592.95m 233.29m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack